Several alternative drug delivery systems to treat glaucoma are currently in the developmental pipeline and could be FDA approved soon.
There is a clear need for alternative glaucoma drug delivery systems to improve medication adherence rates in patients. According to a 2015 study published in Ophthalmology, more than 50% of glaucoma patients are non-adherent with their eye drop medications.
“The problem we face is that our patients don’t reliably take their medications. We do have a paradox, where we have very good treatments for glaucoma, but all of the studies (Read more...)
Uncategorized